(Q37852637)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

1 reference

title

Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Gianni Angelini

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Gavin J. Murphy

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Chris A Rogers

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

published in

Heart Failure Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

553-567

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Acute kidney injury associated with cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Acute kidney injury after cardiac surgery: focus on modifiable risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Inclusion of zero total event trials in meta-analyses maintains analytic consistency and incorporates all available data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

N-Acetylcysteine does not artifactually lower plasma creatinine concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Should we give prophylactic renal-dose dopamine after coronary artery bypass surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Mannitol and Dopamine in Patients Undergoing Cardiopulmonary Bypass: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

RETRACTED: Diltiazem may preserve renal tubular integrity after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Effect of calcium antagonist diltiazem on renal function in open heart surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Effects on renal function of a continuous infusion of nifedipine during cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Efficacy of low-dose continuous infusion of alpha-human atrial natriuretic peptide (hANP) during cardiac surgery: possibility of postoperative left ventricular remodeling effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Effects of human atrial natriuretic peptide in patients after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

RETRACTED: The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

RETRACTED: Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and markers of organ function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

The effect of prostaglandin E1 during cardiopulmonary bypass on renal function after cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Nitric oxide in acute renal failure: NOS versus NOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-011-9235-5

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups

21 January 2018

1 reference

12 December 2020

Improved survival in acute kidney injury after cardiac surgery

1 reference

12 December 2020

Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome

1 reference

12 December 2020

The efficacy of human atrial natriuretic peptide in patients with renal dysfunction undergoing cardiac surgery.

1 reference

12 December 2020

Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function

1 reference

12 December 2020

Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats

1 reference

12 December 2020

Interventions for protecting renal function in the perioperative period

1 reference

12 December 2020

Nitric oxide protects against ischemic acute renal failure through the suppression of renal endothelin-1 overproduction

1 reference

12 December 2020

Lack of renoprotective effects of dopamine and furosemide during cardiac surgery.

1 reference

12 December 2020

Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction

1 reference

12 December 2020

Renal dose dopamine in open heart surgery. Does it protect renal tubular function?

1 reference

12 December 2020

Effect of "renal-dose" dopamine on renal function following cardiac surgery.

1 reference

12 December 2020

Effect of combined dopamine and diltiazem on renal function after cardiac surgery

1 reference

12 December 2020

Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function.

1 reference

12 December 2020

The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial

1 reference

12 December 2020

Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats

1 reference

12 December 2020

N-acetyl cysteine ameliorates ischemic renal failure

1 reference

12 December 2020

Effects of intraoperative administration of atrial natriuretic peptide

1 reference

12 December 2020

Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study

1 reference

12 December 2020

Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients*

1 reference

12 December 2020

Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery.

1 reference

12 December 2020

10.1007/S10741-011-9235-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21400231%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference